Research Article
A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
Table 2
Difference of drug susceptibility between Beijing and non-Beijing families.
| | Characteristic | Number of isolates (%) | value | OR | 95% CI | | Total () | Beijing () | Non-Beijing () |
| | Resistance | | | | | | | | INH | 124 (13.2) | 86 (12.8) | 38 (14.2) | 0.55 | 0.88 | 0.59–1.33 | | RIF | 75 (8.0) | 53 (7.9) | 22 (8.2) | 0.85 | 0.95 | 0.57–1.60 | | SM | 205 (21.8) | 140 (20.8) | 65 (24.3) | 0.24 | 0.82 | 0.58–1.14 | | EMB | 32 (3.4) | 24 (3.6) | 8 (3.0) | 0.66 | 1.20 | 0.53–2.70 | | MDR | 55 (5.9) | 40 (5.9) | 15 (5.6) | 0.85 | 1.06 | 0.58–1.96 | | Four-drug susceptibility | 668 (71.1) | 489 (72.7) | 179 (67.0) | 0.09 | 1.31 | 0.96–1.78 | | Four-drug resistance | 18 (1.9) | 13 (1.9) | 5 (1.9) | 0.95 | 1.03 | 0.36–2.92 |
|
|
INH: isoniazid; RIF: rifampicin; SM: streptomycin; EMB: ethambutol; MDR: multidrug resistance.
OR: odds ratio; 95% CI: 95% confidence interval.
|
